# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects

> **NCT04908800** · PHASE1 · COMPLETED · sponsor: **Kyorin Pharmaceutical Co.,Ltd** · enrollment: 99 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** KRP-A218
- **DRUG:** Placebo
- **DRUG:** itraconazole

## Key facts

- **NCT ID:** NCT04908800
- **Lead sponsor:** Kyorin Pharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-27
- **Primary completion:** 2022-04-21
- **Final completion:** 2022-04-21
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908800, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04908800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*